Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease.
Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease.
复制标题
DOI:
10.1016/j.xcrm.2022.100805
复制
发表时间:
2022-11-15
影响因子:
14.3
通讯作者:
Lipsky, Peter E.
中科院分区:
文献类型:
--
作者:
Kain, Jessica;Owen, Katherine A.;Marion, Miranda C.;Langefeld, Carl D.;Grammer, Amrie C.;Lipsky, Peter E.
Coronary artery disease (CAD) is a leading cause of death in patients with systemic lupus erythematosus (SLE). Despite clinical evidence supporting an association between SLE and CAD, pleiotropy-adjusted genetic association studies are limited and focus on only a few common risk loci. Here, we identify a net positive causal estimate of SLE-associated non-HLA SNPs on CAD by traditional Mendelian randomization (MR) approaches. Pathway analysis using SNP-to-gene mapping followed by unsupervised clustering based on protein-protein interactions (PPIs) identifies biological networks composed of positive and negative causal sets of genes. In addition, we confirm the casual effects of specific SNP-to-gene modules on CAD using only SNP mapping to each PPI-defined functional gene set as instrumental variables. This PPI-based MR approach elucidates various molecular pathways with causal implications between SLE and CAD and identifies biological pathways likely causative of both pathologies, revealing known and novel therapeutic interventions for managing CAD in SLE. Genetic predisposition to SLE confers risk of CAD Increased CVD risk in SLE involves atherosclerosis rather than cardiac dysfunction PPI-based MR identifies pathways with causal implications between SLE and CAD Pathway analysis informs therapeutic selection for managing CAD in SLE Kain et al. report a positive genetic relationship between SLE and CAD using traditional and comprehensive Mendelian randomization (MR) approaches. MR analysis coupled with network modeling highlights the shared genetic risk underlying the two diseases and identifies putative molecular pathways involved in the development of CAD in SLE.
登录
查看更多内容
影响因子:
3.9
作者:
Ajeganova S;Hafström I;Frostegård J
通讯作者:
Frostegård J
DOI:
10.1002/art.39403
发表时间:
2016-01
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
Demirci FY;Wang X;Kelly JA;Morris DL;Barmada MM;Feingold E;Kao AH;Sivils KL;Bernatsky S;Pineau C;Clarke AE;Ramsey-Goldman R;Vyse TJ;Gaffney PM;Manzi S;Kamboh MI
通讯作者:
Kamboh MI
影响因子:
30.8
作者:
Finucane HK;Bulik-Sullivan B;Gusev A;Trynka G;Reshef Y;Loh PR;Anttila V;Xu H;Zang C;Farh K;Ripke S;Day FR;ReproGen Consortium;Schizophrenia Working Group of the Psychiatric Genomics Consortium;RACI Consortium;Purcell S;Stahl E;Lindstrom S;Perry JR;Okada Y;Raychaudhuri S;Daly MJ;Patterson N;Neale BM;Price AL
通讯作者:
Price AL
影响因子:
30.8
作者:
Howson JMM;Zhao W;Barnes DR;Ho WK;Young R;Paul DS;Waite LL;Freitag DF;Fauman EB;Salfati EL;Sun BB;Eicher JD;Johnson AD;Sheu WHH;Nielsen SF;Lin WY;Surendran P;Malarstig A;Wilk JB;Tybjærg-Hansen A;Rasmussen KL;Kamstrup PR;Deloukas P;Erdmann J;Kathiresan S;Samani NJ;Schunkert H;Watkins H;CARDIoGRAMplusC4D;Do R;Rader DJ;Johnson JA;Hazen SL;Quyyumi AA;Spertus JA;Pepine CJ;Franceschini N;Justice A;Reiner AP;Buyske S;Hindorff LA;Carty CL;North KE;Kooperberg C;Boerwinkle E;Young K;Graff M;Peters U;Absher D;Hsiung CA;Lee WJ;Taylor KD;Chen YH;Lee IT;Guo X;Chung RH;Hung YJ;Rotter JI;Juang JJ;Quertermous T;Wang TD;Rasheed A;Frossard P;Alam DS;Majumder AAS;Di Angelantonio E;Chowdhury R;EPIC-CVD;Chen YI;Nordestgaard BG;Assimes TL;Danesh J;Butterworth AS;Saleheen D
通讯作者:
Saleheen D
影响因子:
30.8
作者:
Han, Jian-Wen;Zheng, Hou-Feng;Zhang, Xue-Jun
通讯作者:
Zhang, Xue-Jun